FDA+ channel feed – Endpoints News

FDA+ channel feed

Departing FDA commissioner: 'We're losing the battle on misinformation'

4 months ago

FDA rejects Atara's cell therapy for rare transplant complication, stock craters

4 months ago

Eli Lilly's Omvoh earns FDA approval for Crohn's disease

4 months ago

FDA explains why it rejected Vanda's stomach drug in late 2024

4 months ago

HHS inspector general raises concerns over three FDA accelerated approvals

4 months ago

BIO CEO plans to join FDA modernization advisory board under Trump administration

4 months ago

FDA adcomm votes to support Seikagaku's herniated disc injection

4 months ago

Pfizer touts bladder cancer results as first advancement for some patients 'in decades'

4 months ago

Updated: CDER Director Patrizia Cavazzoni to step down ahead of Trump presidency

4 months ago

Bayer says elinzanetant quelled hot flashes in women undergoing cancer treatment

4 months ago

Catalyst staves off Firdapse competition from Teva for a decade

4 months ago

Pfizer, GSK add risk of Guillain-Barré to RSV vaccine labels at FDA's request

4 months ago

Ahead of adcomm, FDA discusses Seikagaku's mixed trial results for its lumbar disc herniation injection

4 months ago

After a bump in adcomms in 2023, FDA advisory panels returned to 2022 levels

4 months ago

FDA sets an efficacy threshold for future weight loss drugs

4 months ago

Drugmakers cut some list prices, shrinking room for rebates in cancer, asthma and diabetes

4 months ago

FDA offers suite of new guidance on AI, accelerated approvals, clinical trials and more

4 months ago

Every FDA drug approval from 2024: Fewer nods, but long-awaited treatments cross the finish line

4 months ago

Florida car dealer joins insulin pricing fight against Eli Lilly, Sanofi

4 months ago

Novo petitions FDA over Victoza compounding as first generic wins approval

4 months ago

Pennsylvania Blue Cross insurer restricts coverage of medicines granted FDA accelerated approval

4 months ago

FDA adcomm to review Novartis' Fabhalta in ultra-rare kidney disease

4 months ago

FDA approves subcutaneous version of Bristol Myers' Opdivo

5 months ago

Federal appeals court says Teva must delist Orange Book inhaler patents

5 months ago

First page Previous page 7 8 91011 12 13 Next page Last page